Navigation Links
Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
Date:6/18/2008

NEW YORK, June 18 /PRNewswire-FirstCall/ -- Medicsight PLC (AIM: MDST), a subsidiary of MGT Capital Investments, Inc. (Amex: MGT) (the "Company"), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software, today announced that data presented at the recent European Society of Gastrointestinal and Abdominal Radiology (ESGAR) in Istanbul showed that the use of the Medicsight Computer-Aided Detection (CAD) helped radiographers to detect 100% of cancers when examining more than 300 patients in routine primary reporting of virtual colonoscopy (VC).

"These findings are exciting because whilst demand for colorectal cancer investigation is on the rise, there is a shortage of radiologists trained to report VC in many countries," said Dr David Burling, Consultant Radiologist from St Mark's Hospital, London. "If radiographers can be trained to interpret scans more effectively using CAD technology, both radiology teams and patients will benefit, with the ultimate goal of decreasing the incidence and morbidity of colorectal cancer, the second most common cause of death from cancer in Europe."

In the study, 304 patients (61% female) underwent VC as part of routine clinical care. Examinations were read by two trained radiographers supplemented by CAD as a 'second reader'. Radiographers recorded colonic abnormalities and interpretation times and proposed one of six different codes for each examination (Categories S0-5: inadequate/normal/6-9 mm polyp/10mm+ polyp/cancer/diverticular stricture). Findings were compared to that of an experienced radiologist and supplemented by colonoscopic findings if available.

The radiographers, assisted by CAD detected 100% (17/17) of cancers; 72% (21/29) of 10 mm+ polyps and 67% (42/63) of 6-9 mm polyps. Overall agreement between radiographer and radiologist examinations was good, demonstrating that use of CAD by trained radiographers provides an effective triage strategy in initial patient management following VC. Notably on retrospective analysis, CAD had actually detected 60% of polyps missed by radiographers. Therefore, had radiographers accepted these correct CAD annotations, their detection rates would have been 83% and 89% for medium and large polyps respectively.

David Sumner, CEO of Medicsight commented, "This study is yet another positive validated outcome for Medicsight ColonCAD. It further confirms the CAD's accuracy in a user group (Radiographers) that will play a vital role in any colorectal screening programme being implemented in the world today."

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a leading developer of computer-aided detection (CAD) software solutions. Medicsight's CAD solutions help clinicians utilizing Computed Tomography (CT) scans to identify, measure and analyze suspicious pathology within the colon and lungs. The Medicsight CAD products are validated against one of the world's largest databases of verified CT scan data collected from leading healthcare institutions from around the world. Medicsight products allow radiologists and physicians to review scans more quickly and accurately -- saving both time and lives

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at http://www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

Investor & Media Inquiries:

KCSA Strategic Communications

Todd Fromer / Garth Russell

Tel: +1 212-896-1215 / 212-896-1250

tfromer@kcsa.com / grussell@kcsa.com


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
2. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
3. Quantum light beams good for fast technology
4. New Smart Technology Makes Patient Data Collection Easier, More Efficient
5. Align Technology Executive to Present at Upcoming Financial Conferences
6. Pioneer Surgical Technology Hires Vice President of New Business Development
7. Purdue researchers develop technology to detect cancer by scanning surface veins
8. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
9. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
10. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
11. Stevens Health, Technology and Society roundtable: Sept. 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... Deloitte Wisconsin 75, an annual ranking and recognition of the largest closely held ... list, having ranked from 2008-2016. In addition, Standard Process was awarded the Talent ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For ... announced the opening of a new residential mental health treatment program in Chino ... issues such as severe anxiety, depression, bi-polar disorder, and other related issues. , ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and stylish design wanted by today’s consumers at an affordable price, is now ... says the new watch is “a game changer” when it comes to the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... bioLytical Laboratories, ein Weltführer bei schnellen Tests für ... Apothekenbundes von Kenia eingeführt. Continue Reading ... ... Test! (PRNewsFoto/bioLytical Laboratories) ... http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical wurde durch die ...
(Date:12/2/2016)... , December 2, 2016 Orthopedic Implants ... Support) is Expected to Gain a Significant Market Share Owing ... Ailments  ... According to a new ... Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected to ...
(Date:12/2/2016)... December 2, 2016 On Thursday, the ... in red, while the Dow Jones Industrial Average managed to ... of US markets, which prompted Stock-callers this morning to look ... (NASDAQ: NUVA ), Smith & Nephew PLC (NYSE: ... NXTM ), and Cesca Therapeutics Inc. (NASDAQ: KOOL ...
Breaking Medicine Technology: